Psychiatry and Neurology, Neurology · Fort Worth, TX
NPI
1275768657
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
1500 Cooper St
Fort Worth, TX, 76104
Phone (682) 885-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
3,414 services
Medicare patients, 2024
495
Average age 70
Drug cost, 2024
$2.0M
4,527 prescriptions
Company payments, 2025
$6,537
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hamid H Kadiwala was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 317 times for 216 patients. In total Hamid H Kadiwala billed 3,414 services in 23 codes, and Medicare paid $161K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 317 | 216 | $12.84 | $4,071 |
| 99215 Office E&M - Established | Office | 277 | 175 | $138.73 | $38K |
| 99223 Hospital E&M - Initial | Facility | 252 | 242 | $145.08 | $37K |
| 99233 Hospital E&M - Subsequent | Facility | 158 | 139 | $99.29 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 86 | 58 | $66.09 | $5,684 |
| 99205 Office E&M - New | Office | 79 | 79 | $155.98 | $12K |
| 95720 Neurologic | Facility | 76 | 24 | $172.61 | $13K |
| 99214 Office E&M - Established | Office | 59 | 54 | $96.96 | $5,720 |
| 95816 Neurologic | Office | 34 | 33 | $318.36 | $11K |
| 99204 Office E&M - New | Office | 16 | 16 | $141.85 | $2,270 |
By year: 2022 $135K for 1,756 services; 2023 $135K for 2,699 services; 2024 $161K for 3,414 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hamid H Kadiwala prescribed most often to Medicare patients was Levetiracetam, with 478 prescriptions and refills. In total Hamid H Kadiwala wrote 4,527 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 478 | 884 | 108 | $25K |
| Lacosamide Generic | 400 | 496 | 62 | $43K |
| Lamotrigine Generic | 236 | 366 | 36 | $4,896 |
| Donepezil Hcl Generic | 232 | 425 | 66 | $1,957 |
| Gabapentin Generic | 165 | 240 | 29 | $7,112 |
| Memantine Hcl Generic | 161 | 244 | 31 | $2,688 |
| Amitriptyline Hcl Generic | 157 | 198 | 34 | $3,337 |
| Clonazepam Generic | 139 | 153 | 23 | $949 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 135 | 238 | 27 | $3,362 |
| Sertraline Hcl Generic | 134 | 167 | 25 | $487 |
| Topiramate Generic | 115 | 258 | 34 | $1,860 |
| Briviact Brivaracetam | 114 | 116 | 11 | $197K |
| Fycompa Perampanel | 112 | 120 | 17 | $150K |
| Duloxetine Hcl Generic | 112 | 166 | 33 | $1,413 |
| Oxcarbazepine Generic | 109 | 200 | 21 | $14K |
Brand drugs: 706 claims; generic drugs: 3,785 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hamid H Kadiwala $6,537 ($6,537 in general payments such as food, travel and fees) from 36 companies. The largest payer was LivaNova USA, Inc. with $2,625.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 4 | $2,625 |
| Abbvie Inc. ABBV | 64 | $962 |
| UCB, Inc. UCB.BR | 17 | $400 |
| Biogen, Inc. BIIB | 15 | $329 |
| Aucta Pharmaceuticals, Inc. | 26 | $234 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $189 |
| Neurocrine BioSciences, Inc. NBIX | 12 | $179 |
| ACADIA Pharmaceuticals Inc ACAD | 11 | $170 |
| Eisai Inc. 4523.T | 6 | $166 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.